drugset / Trial / NCT05802238

Efficacy of Tranexamic Acid (TXA) in Humerus ORIF

NCT05802238

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if administration of tranexamic acid (TXA), a clotting agent, will decrease blood loss, the need for transfusion, and reduce the likelihood of wound complications such as infection. Investigators will also see if the drug can effectively decrease operative time and length of hospitalization.

Timeline

Start
2023-04-12
Primary completion
2024-11-25
Completion
2024-11-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g

Indications